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Abstract:  
 
The purpose of this study was to examine rates and patterns of 
non–attention-deficit/hyperactivity disorder (non-ADHD) psychiatric diagnoses among a large 
group of 1st-year college students with and without ADHD. A total of 443 participants, including 
214 men and 229 women ranging in age from 18 to 22 years of age (M = 18.2), were recruited 
from 9 colleges involved in a large-scale, multisite longitudinal investigation. Non-Hispanic 
Caucasian students represented 67.5% of the total sample. A comprehensive multimethod 
assessment approach was used in conjunction with expert panel review to determine both ADHD 
and comorbidity status. Significantly higher rates of overall comorbidity were found among 
college students with well-defined ADHD, with 55.0% exhibiting at least one comorbid 
diagnosis and 31.8% displaying two or more, relative to the corresponding rates of nonADHD 
diagnoses among Comparison students, which were 11.2% and 4.0%, respectively. These 
differences in overall comorbidity rates were, in large part, attributable to the increased presence 
of depressive and anxiety disorders, especially major depressive disorder (active or in partial 
remission) and generalized anxiety disorder, among the students with ADHD. Within the ADHD 
group, differential comorbidity rates were observed as a function of ADHD presentation type and 
gender but not ethnic/racial diversity status. The current findings fill a gap in the literature and 
shed new light on the rates and patterns of comorbidity among emerging adults with ADHD in 
their 1st year of college. Implications for providing clinical and support services to college 
students with ADHD are discussed. 
 
Keywords: ​non-ADHD | ADHD | depressive disorders | anxiety disorders | comorbidity 
 
Article: 
 
Similar to many other neurodevelopmental and psychiatric disorders, 
attention-deficit/hyperactivity disorder (ADHD) is often accompanied by co-occurring or 
comorbid conditions. Among children with ADHD, comorbidity rates are typically quite high but 
can vary substantially depending on the nature of the sample, sampling techniques, the 
diagnostic criteria used, and other factors. In a recent investigation using a large community 
sample, Willcutt et al. (2012) found that up to 44% of children and adolescents with ADHD 
exhibited at least one comorbid condition and that as many as 43% displayed two or more 
disorders. Even higher comorbidity rates have been identified in clinic-referred samples, with 
60%–80% of children and adolescents with ADHD having one additional diagnosis and as many 
as 50% displaying two or more comorbid conditions (Pliszka, 2014). Disruptive behavior 
disorders, such as oppositional defiant disorder (ODD) and conduct disorder (CD), are especially 
common comorbid conditions in youth with ADHD. Although occurring less frequently, mood 
and anxiety disorders, learning disabilities, and other psychiatric and developmental conditions 
have been found to co-occur with ADHD at rates higher than that in the general population 
(Angold, Costello, & Erkanli, 1999; DuPaul, Gormley, & Laracy, 2013; Nigg & Barkley, 2014). 
Adults with ADHD also display high comorbidity rates. Based upon their examination of 
data obtained from both cross-sectional and longitudinal samples, Barkley and colleagues 
(Barkley, Murphy, & Fischer, 2008) found that 80.0%–84.3% of adults with ADHD experienced 
at least one comorbid condition, and 53.0%–60.8% exhibited two or more. More so than for 
children, mood and anxiety disorders occur at higher rates among adults with ADHD. As 
reported by Kessler et al. (2006), 12-month rates of mood disorders were 38.3% for adults with 
ADHD versus 11.1% for non-ADHD adults; similarly, anxiety disorders were evident in 47.1% 
of adults with ADHD versus 19.5% for the non-ADHD group. Along with mood and anxiety 
disorders, adults with ADHD are at risk for other comorbid conditions, albeit at lower rates 
(Biederman, Petty, Evans, Small, & Faraone, 2010; Garcia et al., 2012). 
Although it is well-established that ADHD is often accompanied by other conditions, the 
manner in which comorbidity unfolds across development is not well understood. Further 
limiting our understanding is that, although there has been an abundance of research examining 
comorbidity among child and adult ADHD populations, much less attention has been focused on 
the rates and patterns of comorbidity among individuals with ADHD, 18 to 25 years of age, who 
are transitioning through the developmental period known as emerging adulthood (Arnett, 2007). 
Longitudinal investigations that began following hyperactive children in the 1970s have 
provided initial insights into the outcomes of emerging adults with ADHD (Barkley et al., 2008; 
Mannuzza, GittelmanKlein, Bessler, Malloy, & LaPadula, 1993; Weiss & Hechtman, 1993). 
More recently, most of what is known about this age group has been gleaned from 
cross-sectional investigations using college populations. One reason for focusing on college 
students is that increasing numbers of individuals with ADHD have been entering college 
(DuPaul & Weyandt, 2009), with estimates of the prevalence of ADHD among college students 
ranging from 2% to 8% (DuPaul et al., 2001; Eagan et al., 2014; McKee, 2008). Conceptual 
justification for studying college students with ADHD stems from a consideration of their 
increased risk for negative outcomes, due to a “perfect storm” of circumstances that converge 
upon them (Anastopoulos & King, 2015). For any individual attending college for the first time, 
adjustments must be made with respect to the increased demands for selfregulation inherent in 
the college experience. For 1styear students with ADHD whose capacity for self-regulation is 
limited (Barkley et al., 2008), mastering this developmental challenge can be substantially more 
difficult (Fleming & McMahon, 2012), especially when accompanied by withdrawal of parental 
monitoring, medication regimens, school accommodations, and other supports that may have 
been in place prior to attending college (Meaux, Green, & Broussard, 2009). Moreover, upon 
entering college, many students with ADHD may not seek out campus resources that could 
provide them with the types of support services they need. Consistent with this perfect storm 
conceptualization, college students with ADHD have been shown to be at increased risk for 
experiencing significant educational and social impairment. For example, relative to peers 
without ADHD, college students with ADHD have significantly lower grade point averages, take 
longer to receive their degrees, and are more likely to drop out (Advokat, Lane, & Luo, 2011; 
Barkley et al., 2008; Faraone & Biederman, 2005; Weyandt & DuPaul, 2013). College students 
with ADHD are also at increased risk for having lower levels of social adjustment and social 
skills, engaging in risky sexual behavior, and experiencing driving-related difficulties (Barkley et 
al., 2008; Janusis & Weyandt, 2010; Rooney, Chronis-Tuscano, & Yoon, 2012). 
The extent to which comorbid conditions may exist and contribute to impairment in the 
educational and social functioning of college students with ADHD is unclear. Such uncertainty is 
in large part due to the fact that mixed results have emerged from the relatively small number of 
studies that have addressed these issues. Based on their chart review of 42 students with ADHD 
presenting at a university health center, Heiligenstein and Keeling (1995) reported a 55% overall 
rate of comorbidity, primarily involving mood disorders (26%) and, to a much lesser extent, 
anxiety disorders (5%). In a subsequent chart review study, Heiligenstein, Guenther, Levy, 
Savino, and Fulwiler (1999) compared college students with and without ADHD but found no 
differences between these groups on dimensional self-report ratings of psychological 
functioning. Nelson and Gregg (2012) also failed to find differences between college students 
with and without ADHD on dimensional measures of depression and anxiety. Others, however, 
have found differences for dimensional depression (Rabiner, Anastopoulos, Costello, Hoyle, & 
Swartzwelder, 2008) and anxiety (Richards, Rosen, & Ramirez, 1999). 
Complicating matters are numerous methodological limitations. Of particular concern is 
that most studies defined ADHD status in less than rigorous ways, including retrospective record 
reviews and self-report of previously diagnosed ADHD status (Heiligenstein & Keeling, 1995; 
Heiligenstein et al., 1999; Rabiner et al., 2008). A notable exception to this was evident in the 
Nelson and Gregg (2012) study, which used a multimethod procedure to identify participants 
with ADHD. This same assessment approach, however, was not used to evaluate comorbidity. 
The manner in which comorbidity has been evaluated in other studies has also been limited in 
both rigor and scope. With only one exception (Heiligenstein & Keeling, 1995), comorbidity was 
determined on the basis of dimensional self-report ratings of psychopathology in the absence of 
clinical interviewing (Heiligenstein et al., 1999; Rabiner et al., 2008; Richards et al., 1999). 
Thus, it is not possible to ascertain whether observed comorbid features reached a level of 
clinical significance warranting a formal diagnosis as defined in the fifth edition of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-5; American Psychiatric 
Association, 2013) or in any of its predecessors (e.g., DSM-IV-TR; American Psychiatric 
Association, 2000). In addition, the extant literature has not yet systematically examined the 
potential influence of ADHD presentation type and demographic factors (e.g., gender, 
ethnic/racial diversity) on comorbidity status among college students. ADHD presentation type is 
of particular importance, given that the Combined type, a more severe form of ADHD, is more 
often associated with comorbidity in child and adult ADHD populations (Nigg & Barkley, 2014).  
As a context for understanding comorbidity among college students with ADHD, it is 
important to consider recent findings pointing to a rise in mental health problems in the general 
college student population within the United States (Clay, 2013). As many as 12%–18% have 
been shown to have a diagnosable mental health condition (Mowbray et al., 2006), with mood 
and anxiety disorders being especially common, occurring in 10.6% and 11.9% of the general 
college population, respectively (Blanco et al., 2008). Similar findings have been reported for 
college students in other countries (Verger, Guagliardo, Gilbert, Rouillon, & Kovess-Masfety, 
2010). Such mental health problems place college students at risk for significant educational, 
social, and personal difficulties (Eisenberg, Gollust, Golberstein, & Hefner, 2007). Given that 
children and adults with ADHD are at substantially higher risk for comorbid psychiatric 
conditions, it is reasonable to speculate that college students with ADHD would also display 
higher rates of comorbid psychiatric disorders relative to their non-ADHD college peers. Such 
increased risk may in turn contribute to the educational and social impairments that have been 
identified in this population (Advokat et al., 2011; Barkley et al., 2008; Faraone & Biederman, 
2005). 
To gain greater understanding of comorbidity issues within the ADHD college 
population, the purpose of this study was to examine rates and patterns of nonADHD psychiatric 
diagnoses among a large group of college students with and without ADHD. In contrast with 
prior research, the current investigation used a comprehensive, multimethod assessment 
approach and expert panel review to ascertain both ADHD and comorbidity status. Based on 
what is known about comorbidity among children and adults with ADHD, it was hypothesized 
that there would be continuity across development, such that college students with ADHD would 
show higher rates of other psychiatric conditions relative to a non-ADHD comparison group. At 
the same time, however, it was expected that the magnitude of the comorbidity rates among 
1st-year college students with ADHD, who represent an educationally more successful segment 
of the ADHD population and who have not been in college long enough to be impacted by the 
perfect storm, would be less than that typically reported for the general population of children 
and adults with ADHD. A secondary goal of this study was to examine the potential influence of 
ADHD presentation type, gender, and ethnic/racial diversity status. Consistent with findings 
from child and adult ADHD populations (Barkley et al., 2008; Nigg & Barkley, 2014), higher 
rates of comorbidity were expected for students with a Combined presentation versus a 
Predominantly Inattentive presentation. Given that female adults with ADHD may be at 
increased risk for depression and anxiety, whereas male adults with ADHD are more inclined to 
display conduct-related problems (Cumyn, French, & Hechtman, 2009), differential gender 
patterns of comorbidity were also expected. In the absence of systematic research addressing 
ethnic and racial characteristics within ADHD populations, the association between ethnic/racial 
diversity status and comorbidity was examined on an exploratory basis. 
 
Method 
 
Participants 
 
A total of 527 first-year college students were initially screened to determine their eligibility for 
the Trajectories Related to ADHD in College (TRAC) project, a 5-year multisite longitudinal 
investigation. Of that number, 456 met the study’s eligibility requirements; 13, however, 
withdrew from the project before completing the second of a four-stage assessment process. 
Thus, the sample for the current study comprised 443 participants—214 men and 229 women 
ranging in age from 18 to 22 years (M = 18.2). Approximately 10.6% of the participants reported 
having Hispanic backgrounds. The racial composition of the sample was 71.1% Caucasian, 
12.6% African American, 5.6% Asian, 3.8% multiracial, and 6.8% from other racial 
backgrounds. Non-Hispanic Caucasian students represented 67.5% of the total sample. 
To be eligible for the ADHD group, participants were required to meet DSM-5 criteria 
(American Psychiatric Association, 2013). ADHD status, as well as non-ADHD comparison 
group status, was determined on the basis of a multigating, multimethod assessment procedure 
that included expert panel review. At the first stage of this assessment process, all participants 
initially completed a self-report ADHD Rating Scale (DuPaul, Power, Anastopoulos, & Reid, 
1998), which was modified to address current and past ADHD symptoms, as well as medication 
status. If a participant’s self-report or parent-report indicated that he or she frequently displayed 
four or more symptoms of either inattention or hyperactivity-impulsivity during both childhood 
and the past 6 months, a semistructured interview for adult ADHD was then administered to 
address full DSM-5 criteria for ADHD, including the requirement of five or more symptoms of 
either inattention or hyperactivity-impulsivity being present. This same interview was 
administered to potential comparison participants whose self- and parent-reported responses to 
the ADHD Rating Scale indicated the presence of three or fewer symptoms for both inattention 
and hyperactivity-impulsivity during childhood and during the past 6 months. Participants whose 
interview responses continued to suggest the presence of three or fewer symptoms from both 
symptom lists were deemed eligible for the comparison group. All potentially eligible cases were 
then reviewed by a panel of four ADHD experts (i.e., the three principal investigators and a 
nationally recognized adult ADHD consultant). Unanimous panel agreement was required for 
final determination of ADHD and comparison group status, as well as for comorbidity status. 
As can be seen in Table 1, the ADHD (n = 220) and comparison (n = 223) groups were 
statistically equivalent with respect to age, gender, and ethnic/racial diversity status, all of which 
were consistent with the demographics of the universities from which they were drawn. As 
expected, the two groups differed in terms of their self-reported ADHD symptoms. Within the 
ADHD group, there were 48.2% with a Combined presentation, 46.8% with a Predominantly 
Inattentive presentation, and 5.0% with a Predominantly Hyperactive-Impulsive presentation. 
 
Table 1. Participant Demographic and ADHD Features by Group 
 
Note. Attention-deficit/hyperactivity disorder (ADHD) group n = 220, comparison group n = 
223. CAARS = Conners Adult ADHD Rating Scale; DSM = Diagnostic and Statistical Manual 
of Mental Disorders IN = Inattention T score; HI = Hyperactivity-Impulsivity T score.  
*p < .001. 
 
Measures 
 
Background Information. All participants completed a one-page information form to 
provide demographic and contact information. Participants also underwent a background 
interview to provide information about their K-12 school history, family of origin demographics, 
and personal and family histories of mental health difficulties. 
 
ADHD Rating Scale, Self-Report Version (ADHD RS-SRV). The ADHD RS-SRV, 
developed specifically for the purposes of this study, is a modified version of the ADHD RS-IV 
(DuPaul et al., 1998). Like its predecessor, the ADHD RS-SRV lists the inattention (IN) and 
hyperactive-impulsive (HI) symptoms in alternating fashion, and the frequency of occurrence for 
each symptom can be rated as: 0 (never or rarely present), 1 (sometimes present), 2 (often 
present), or 3 (very often present). Summing the number of items scored 2 or 3 yields symptom 
frequency counts for both IN and HI, which were used for eligibility screening purposes. Unlike 
the ADHD RS-IV, the ADHD RS-SRV addresses ADHD symptoms both during childhood and 
during the past 6 months while taking into account medication status. In the current study 
coefficient alphas were very good (.74) to excellent (.94) for the childhood and past 6 months 
reports of both IN and HI symptoms, regardless of medication status. There was also evidence of 
concurrent validity, with correlations between the IN and HI scores and their respective Conners 
Adult ADHD Rating Scale, Self-Report, Long Form (CAARS-S:L) dimensions ranging from .27 
to .92 (all ps < .01). 
 
ADHD Rating Scale, Parent-Report Version. The ADHD RS-PRV is a modified version 
of the ADHD RS-IV (DuPaul et al., 1998), requiring parents to rate their child’s ADHD 
symptoms during both childhood and the past 6 months. For participants with histories of taking 
ADHD medication, parents were instructed to provide ratings based on their child’s status when 
not taking medication. The format and scoring of the ADHD RS-PRV are similar to that of the 
ADHD RS-SRV. In the current study the ADHD RS-PRV demonstrated excellent psychometric 
properties, with high internal consistency (.89–.94), and correlations between the IN and HI 
scores and corresponding CAARSS:L dimensions ranging from .49 to .61 (all ps < .001). 
 
Semi-Structured Interview for Adult ADHD. The Semi-Structured Interview for Adult 
ADHD was developed specifically for this study. We opted to use a study-specific interview 
rather than one previously developed because it allowed us to assess (a) functional impairment 
for each of the 18 symptoms, and (b) symptom frequency counts for times when on and off 
medication. The nine IN symptoms are presented first, followed by the nine HI symptoms. For 
each symptom endorsed as being present “most of the time,” additional questioning examines 
that symptom’s impact on daily functioning. After reviewing all IN and HI symptoms, further 
questioning addresses the duration, age of onset, and other DSM-5 criteria for ADHD. For 
participants whose initial responses were based on functioning while taking medication, 
follow-up questioning was conducted to assess symptom frequency when not taking medication. 
In the current study, coefficient alphas for both the IN and HI portions of the interview were 
excellent (.90 and .85, respectively), and both symptom dimensions were highly correlated with 
their respective CAARS-S:L dimensions (.78 and .84, respectively). 
 
Structured Clinical Interview for DSM Disorders (SCID-I). The SCID-I (First, Spitzer, 
Gibbon, & Williams, 1996) is a psychometrically sound interview used widely in clinical 
research. The SCID-I Mood and Anxiety Disorders modules were administered to all 
participants. Although many researchers routinely administer all SCID-I modules, this was not 
possible within the time parameters and resources of the current study. Instead, other SCID-I 
modules were given only to participants reporting a personal or family history of psychiatric 
disorders during the background interview. Because DSM-5 criteria had not yet been finalized at 
the time these data were collected, DSM-IV guidelines were used to assess these non-ADHD 
conditions. Diagnoses generated from the SCID-I served to identify mental health conditions that 
might rule out ADHD, be comorbid with ADHD, or be present among comparison participants. 
 
Conners Adult ADHD Rating Scale, Self-Report, Long Form (CAARS-S:L). The 
CAARS-S:L (Conners, Erhardt, & Sparrow, 2006) is a frequently used self-report measure of 
adult ADHD symptoms that has been used extensively in research and clinical practice. The 
CAARSS:L is psychometrically sound and well standardized, allowing for normative data 
comparisons. In this study the DSM-IV Inattentive Symptoms and Hyperactive-Impulsive 
Symptoms T scores were used to assess the severity of ADHD symptoms across groups. 
 
Beck Depression Inventory-II (BDI-II). The BDI-II (Beck, Steer, & Brown, 1996) is 
self-report measure of depression that is psychometrically sound (coefficient α = .92 in this 
study) and has been widely used in research and clinical practice. The total score from the BDI-II 
was used as a dimensional measure of depression. 
 
Beck Anxiety Inventory (BAI). The BAI (Beck & Steer, 1993) is often used in research 
and clinical practice and possesses adequate psychometric properties (studyspecific coefficient α 
= .92). In this study the BAI total score served as a dimensional measure of anxiety. 
 
Externalizing Behavior Rating Scale (EBRS). The EBRS is a study-specific measure to 
assess self-reported symptoms of ODD and CD. Modeled after the ADHD RS, the EBRS first 
lists the eight ODD symptoms, followed by the 12 (out of 15) CD items deemed developmentally 
appropriate for a college population. Each EBRS item is rated on a 0 (not at all) to 3 (very much) 
scale reflecting the degree to which items characterize a participant’s behavior over the past 6 
months. Items are then summed to yield separate ODD and CD total scores, which were used as 
dimensional outcome measures. Internal consistency for all 20 items was .83, with coefficient 
alphas of .85 and .66 noted for the ODD and CD portions of the scale, respectively. Preliminary 
validity information comes from the finding that the ODD and CD portions of the scale correlate 
significantly with the CAARS ADHD Index (.68 and .33, respectively). 
 
Procedure 
The TRAC project is a 5-year longitudinal investigation of 1st-year college students with and 
without ADHD. The goal of TRAC is to examine multiple functional trajectories (e.g., 
educational, behavioral, social, vocational) across this early period of emerging adulthood and to 
identify risk and protective factors that inform clinical assessment and treatment. Three primary 
sites are involved, including one university in the Southeast and two universities in the Northeast 
United States. In addition, six colleges and universities near the primary sites served exclusively 
as recruitment sites. To achieve recruitment goals, two cohorts of 1st-year students were 
recruited successively across the first 2 years of the project. A total of 219 participants were 
recruited in Cohort 1, and another 237 participants were recruited in Cohort 2. All participants 
underwent an annual four-stage assessment process, for which they earned up to $100 as an 
incentive for completing all required procedures. Recruitment and data collection occurred 
continuously throughout the fall and spring semesters at times convenient to each participant. 
Data collected from the first of four planned annual assessments were used in this study. 
Participants were recruited from multiple sources, including summer orientation sessions, 
disability services, student counseling centers, fliers, and presentations to large 1st-year classes. 
Students who were between 18 and 25 years of age and entering college for the first time were 
recruited and, subsequent to providing informed consent, asked to complete the current and 
childhood self-report versions of the ADHD RS. Students’ parents were also asked to complete 
the ADHD RS, addressing both current and childhood symptoms. Data collected from these self- 
and parent-report versions of the ADHD RS served as the basis for determining which 
participants moved on to the next assessment phase, involving the Semi-Structured Interview for 
Adult ADHD. Information from this interview and the SCID-I was then used to determine which 
cases would be forwarded to the expert panel for final determination of ADHD or comparison 
group classification, as well as non-ADHD psychiatric status. Background history, service 
utilization data (e.g., prior special education services), and IQ-achievement discrepancies were 
similarly forwarded to the panel for determination of learning disability status. For cases lacking 
unanimous panel agreement, weekly conference calls were conducted for the purpose of 
resolving these differences of opinion and ultimately reaching a unanimous decision. 
All data were collected by predoctoral and doctoral-level staff from clinical psychology 
and school psychology backgrounds. All staff received extensive training prior to the start of the 
project, and their adherence to the various assessment protocols was monitored on an ongoing 
basis to maintain consistency across sites. All study procedures are reviewed on an annual basis 
and were approved by the Institutional Review Boards at each site. 
 
Planned Statistical Analyses 
 
Chi-square analyses were conducted to address the primary hypothesis comparing the two groups 
categorically on overall and disorder-specific rates of non-ADHD conditions. Independent 
sample t tests were used to assess dimensional differences in symptoms of depression, anxiety, 
oppositional defiant behavior, and conduct problems. Using ADHD group data only, similar 
categorical and dimensional analyses were performed to examine the association of ADHD 
presentation, gender, and ethnic/racial diversity status with comorbidity. Although DSM-IV 
criteria were used to determine non-ADHD diagnostic status, all categorical results are presented 
in a manner consistent with DSM-5 groupings of these disorders. For all categorical analyses, 
alpha was set at .01 based upon a Bonferroni family-wise correction for the number of 
psychiatric domains that were evaluated (e.g., mood, anxiety, obsessive compulsive disorder 
[OCD], trauma & stressor, and eating). For all dimensional analyses, each of which involved 
four comparisons, a Bonferroni-corrected alpha of .0125 was used. 
 
Results 
 
Comorbidity by Group 
 
The overall rate of having one current non-ADHD diagnosis was significantly higher for the 
ADHD group (55%) versus the comparison group (11.2%), χ​2​ (1) = 96.1, p < .001, with a 
corresponding odds ratio (OR) = 9.7, 95% confidence interval (CI) [5.9, 15.8]. The ADHD group 
also displayed a substantially higher rate of having two or more current non-ADHD disorders 
(31.8% vs. 4.0%), χ​2​ (1) = 58.3, p < .001, OR = 11.1, 95% CI [5.4, 22.9]. 
As shown in Table 2, observed differences in overall comorbidity rates are largely due to 
group differences in current depressive and anxiety disorders. The rate of having any depressive 
disorder, which included consideration of major depressive disorder (MDD), dysthymic 
(persistent depressive) disorder, and depression not otherwise specified (other specified 
depressive disorder), was 32.3% for the ADHD group and 5.4% for the comparison group, χ​2​ (1) 
= 52.6, p < .001, OR = 8.4, 95% CI [4.4, 16.0]. MDD in particular, which included both single 
and recurrent episodes that were either active or in partial remission, accounted for much of this 
difference (28.2% vs. 3.6%), χ​2​ (1) = 50.4, p < .001, such that the ADHD group was at a 10.5 
increased risk for having MDD, 95% CI [4.9, 22.7]. The ADHD group also displayed a 
significantly higher rate (28.6% vs. 3.6%), χ​2​ (1) = 51.6, p < .001, and risk, OR = 10.8, 95% CI 
[5.0, 23.1], for having a current anxiety disorder, which took into account generalized anxiety 
disorder (GAD), panic disorder, social phobia (social anxiety disorder), specific phobia, and 
anxiety disorder not otherwise specified (other specified anxiety disorder). Among these, GAD 
occurred the most often, accounting for most of this difference. 
Additional group differences were evident with respect to trauma- and stressor-related 
disorders, with rates of 7.3% and 0.9% occurring in the ADHD and comparison groups, 
respectively, χ​2​ (1) = 11.6, p = .001, OR = 8.7, 95% CI [2.0, 38.2]. Much of this difference 
stemmed from the ADHD group exhibiting higher rates (5.0% vs. 0.4%), χ​2​ (1) = 8.7, p = .003, 
and risk, OR = 11.7, 95% CI [1.5, 91.3], for adjustment disorders relative to the comparison 
group. No further group differences emerged with respect to the other psychiatric disorders that 
were assessed, including bipolar disorder, OCD, and eating disorders. The two groups differed, 
however, with respect to learning disorders (LD), with the ADHD group displaying a 
significantly higher rate (10.0% vs. 0.4%), χ​2​ (1) = 20.5, p < .001, and risk, OR = 24.7, 95% CI 
[3.3, 184.7] than the Comparisons. 
 
Table 2. Comorbid and Non-ADHD Disorders by Group 
 
Note. OR = odds ratio; CI = confidence interval; ADHD = attention deficit/hyperactivity 
disorder; MDD = major depressive disorder; NOS = not otherwise specified; GAD = generalized 
anxiety disorder; OCD = obsessive-compulsive disorder; PTSD = posttraumatic stress disorder; 
LD = learning disorder.  
a​ Fisher’s Exact Test used in place of chi-square due to zero value in one cell. Total percentages 
may exceed 100% due to participants having two or more diagnoses. 
 
Table 3. Means and Standard Deviations of Dimensional Measures by Group 
 
Note. Clinical cutoff scores for the BDI-II and BAI are 14 and 8, respectively. ADHD = 
attention-deficit/hyperactivity disorder; BDIII = Beck Depression Inventory-Second Edition; 
BAI = Beck Anxiety Inventory; EBRS = Externalizing Behavior Rating Scale; ODD = 
oppositional defiant disorder; CD = conduct disorder. 
The results of the dimensional analyses (Table 3) were consistent with the categorical 
depression findings, showing higher BDI-II severity levels for the ADHD group relative to the 
comparison group, t(441) = 13.1, p < .001. The same was true for anxiety, with significantly 
higher BAI scores noted among the ADHD group versus the comparison group, t(441) = 11.8, p 
< .001. The ADHD group also reported significantly higher severity scores for both ODD and 
CD symptoms, p < .001. With the exception of CD (d = .66), effect sizes were large for these 
group differences in depression (d = 1.25), anxiety (d = 1.12), and ODD (d = 1.31). 
 
Comorbidity by ADHD Presentation Type 
 
Due to the small number of participants displaying a predominantly hyperactive-impulsive 
presentation (5%), only cases with either a combined (n = 106) or predominantly inattentive (n = 
103) presentation were included in the analyses of ADHD clinical presentation. The combined 
group displayed a significantly higher overall rate of having one current comorbid diagnosis 
relative to those with an inattentive presentation, 67.0% versus 46.6%, χ​2​(1) = 8.8, p = .003. This 
difference represented an increased risk of 2.3, 95% CI [1.3, 4.1], for the combined group. The 
combined and inattentive groups did not differ, however, with respect to having two or more 
comorbid disorders (37.7% vs. 28.2%). 
Rates of current depressive disorders (Table 4) were significantly higher for those with a 
combined presentation (42.5% vs. 24.3%), χ​2​(1) = 7.8, p = .005, primarily due to higher rates of 
MDD within the combined group, χ2 (1) = 8.4, p = .004. A similar pattern emerged with respect 
to risk for any depressive disorder, OR = 2.3, 95% CI [1.3, 4.2], as well as for MDD in 
particular, OR = 2.5, 95% CI [1.3, 4.6]. No other findings were statistically significant, but 
trends were noted in terms of OCD (p = .03) and eating disorders (p = .06), with the combined 
group displaying higher rates of both disorders (6.6% vs. 1% and 3.8% vs. 0%, respectively). 
The results of the dimensional analyses (Table 5) were consistent with the categorical 
depression findings but differed with respect to anxiety. Specifically, the combined group 
reported significantly higher severity scores for both depression, t(207) = 2.6, p = .01, and 
anxiety, t(207) = 3.2, p = .002, than did the inattentive group. The combined group also reported 
significantly higher severity scores for ODD, t(198) = 5.5, p < .001, but not for CD. The 
magnitude of these ODD symptom differences was medium to large (d = .79), whereas those for 
both depression (d = .35) and anxiety (d = .44) represented small to medium effects.  
 
Comorbidity by Gender 
 
Within the ADHD group, women (n = 114) displayed significantly higher rates of having one 
comorbid disorder than did men (n = 106; 68.4% vs. 40.6%), χ​2​(1) = 17.2, p < .001, with a 
corresponding OR = 3.2, 95% CI [1.8, 5.5]. Women also displayed higher rates of (43.9% vs. 
18.9%), χ​2​(1) = 15.8, p < .001, and risk for, OR = 3.4, 95% CI [1.8, 6.2], having two or comorbid 
disorders than did men. 
 
Table 4. Comorbid Diagnoses by Attention-Deficit/Hyperactivity Disorder Presentation 
 
Note. OR = odds ratio; CI = confidence interval; MDD = major depressive disorder; NOS = not 
otherwise specified; GAD = generalized anxiety disorder; OCD = obsessive-compulsive 
disorder; PTSD = posttraumatic stress disorder; LD = learning disorder.  
a​ Fisher’s Exact Test used in place of chi-square due to zero value in one cell. Total percentages 
may exceed 100% due to participants having two or more diagnoses. 
 
Table 5. Means and Standard Deviations of Dimensional Measures by 
Attention-Deficit/Hyperactivity Disorder Presentation 
 
Note. Clinical cutoff scores for the BDI-II and BAI are 14 and 8, respectively. BDI-II = Beck 
Depression Inventory-Second Edition; BAI = Beck Anxiety Inventory; EBRS = Externalizing 
Behavior Rating Scale; ODD = oppositional defiant disorder; CD = conduct disorder. 
 
As shown in Table 6, much of this overall comorbidity difference was related to higher 
rates of and risk for current depressive disorders, especially MDD, among women (43.0%) 
versus men (20.8%), χ​2​(1) = 12.4, p < .001, OR = 2.9, 95% CI [1.6, 5.2]. Women with ADHD 
also exhibited significantly higher rates of anxiety disorders (39.5% vs. 17.0%), χ​2​(1) = 13.6, p < 
.001, reflecting an increased risk of 3.2, 95% CI [1.7, 6.0]. None of the remaining gender 
analyses was statistically significant, but two trends did emerge, suggesting higher rates of 
trauma and stressor-related disorders (p = .05) and eating disorders (p = .04) among women 
(10.5% vs. 3.8% and 4.4% vs. 0%, respectively). 
A summary of the independent t-test analyses of the dimensional data appears in Table 7. 
Consistent with the categorical findings, women reported higher levels of depression, t(218) = 
3.2, p = .002, and anxiety, t(218) = 3.1, p = .002, than did men. No differences emerged with 
respect to ODD symptoms, but as expected, men reported higher levels of CD symptoms, t(209) 
= 3.5, p = .001. Such differences in comorbid internalizing and externalizing symptoms were 
small to medium in magnitude, ranging from d = .43 to d = .46. 
 
Table 6. Comorbid Diagnoses Within Attention-Deficit/Hyperactivity Disorder Group by Gender 
 
Note. OR = odds ratio; CI = confidence interval; MDD = major depressive disorder; NOS = not 
otherwise specified; GAD = generalized anxiety disorder; OCD = obsessive-compulsive 
disorder; PTSD = posttraumatic stress disorder; LD = learning disorder.  
a​ Fisher’s Exact Test used in place of chi-square due to zero value in one cell. Total percentages 
may exceed 100% due to participants having two or more diagnoses. 
 
 
 
 
 
 
Table 7. Means and Standard Deviations of Dimensional Measures Within 
Attention-Deficity/Hyperactivity Disorder Group by Gender 
 
Note. Clinical cutoff scores for the BDI-II and BAI are 14 and 8, respectively. BDI-II = Beck 
Depression Inventory-Second Edition; BAI = Beck Anxiety Inventory; EBRS = Externalizing 
Behavior Rating Scale; ODD = oppositional defiant disorder; CD = conduct disorder. 
 
Comorbidity by Ethnic/Racial Diversity Status 
 
Within the ADHD group, categorical and dimensional comparisons were conducted between 
participants self-identifying as being non-Hispanic Caucasian (n = 157) or as having Hispanic 
ethnicity and/or African American, Asian, multiracial, or other racial backgrounds (n = 63). No 
group differences were found for any of the categorical analyses, addressing rates of and risk for 
depressive disorders, anxiety disorders, bipolar disorders, OCD, trauma- and stressor related 
disorders, eating disorders, and LD. The dimensional analyses of depression, anxiety, and CD 
did not reveal significant differences. There was, however, one dimensional analysis that yielded 
a statistically significant finding, showing slightly higher levels of ODD symptoms among 
participants from ethnically/racially diverse backgrounds (M = 9.6, SD = 4.5) relative to those 
from non-Hispanic Caucasian backgrounds (M = 8.2, SD = 4.4), t(209) = 2.0, p = .04, d = .31. 
 
Discussion 
 
The current study used a comprehensive multimethod assessment approach in conjunction with 
expert panel review to determine both ADHD and comorbidity status. Results revealed a high 
rate of comorbidity among college students with well-defined ADHD, with 55.0% exhibiting at 
least one current comorbid diagnosis and 31.8% displaying two or more. Consistent with study 
expectations, these overall comorbidity rates within the ADHD group were significantly higher 
than the corresponding rates of non-ADHD diagnoses among Comparison students, which were 
11.2% and 4.0%, respectively. Generally speaking, these elevated ADHD comorbidity rates 
among emerging adults in college are higher than the overall comorbidity rates reported for a 
community sample of children and adolescents with ADHD (Willcutt et al., 2012) but lower than 
those reported for adults with ADHD (Barkley et al., 2008). Such findings, although 
cross-sectional in nature, raise the possibility that there may indeed be continuity in the 
developmental unfolding of comorbid conditions among individuals with ADHD. 
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Generally speaking, these elevated ADHD comorbidity rates among emerging adults in college 
are higher than the overall comorbidity rates reported for a community sample of children and 
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diagnoses among Comparison students, which were 11.2% and 4.0%, respectively. 
Generally speaking, these elevated ADHD comorbidity rates among emerging adults in college 
are higher than the overall comorbidity rates reported for a community sample of children and 
adolescents with ADHD (Willcutt et al., 2012) but lower than those reported for adults with 
ADHD (Barkley et al., 2008). Such findings, although cross-sectional in nature, raise the 
possibility that there may indeed be continuity in the developmental unfolding of comorbid 
conditions among individuals with ADHD. 
Further examination of the ADHD group revealed that college students with a combined 
presentation displayed a higher overall rate of comorbidity than those with a predominantly 
inattentive presentation, largely due to more frequent reports of current depressive disorders. 
Dimensional analyses also revealed significantly higher levels of anxiety and ODD symptoms in 
the combined group. Together, such findings are consistent with the view that the combined type 
represents a more severe ADHD presentation. Gender differences within the ADHD group were 
evident as well, with women reporting higher overall comorbidity rates. Much of this gender 
difference stems from significantly higher rates of current depressive and anxiety disorders, and 
to a lesser extent, from higher rates of eating disorders and trauma- & stressor-related disorders. 
In contrast with these categorical outcomes, the dimensional analyses revealed higher levels of 
self-reported CD symptoms among men than women. Such gender-related differences in 
observed rates and patterns of internalizing and externalizing symptoms are consistent with 
previously reported findings among adults with ADHD, as well as in the general population 
(Cumyn et al., 2009). Exploratory examination of the impact of ethnic/ racial diversity within the 
ADHD group revealed slightly higher dimensional levels of ODD symptoms among participants 
from ethnically/racially diverse backgrounds. Apart from this finding, no other significant 
dimensional or categorical differences emerged from the comparisons of participants 
self-identifying as non-Hispanic Caucasian and those self-identifying as having Hispanic 
ethnicity and/or African American, Asian, multiracial, or other racial backgrounds. 
The aforementioned findings must, of course, be considered in light of limitations 
inherent in this investigation. This study did not, for example, address the conceptual matter of 
why so many different conditions co-occur with ADHD. Although it is commonly assumed that 
having ADHD increases the risk of developing another disorder, additional research is needed to 
disentangle whether the comorbidity associated with ADHD is due to increased risk versus other 
possible explanations, such as shared etiological mechanisms or overlapping symptoms 
(Lilienfeld, Waldman, & Israel, 1994). Methodological limitations need to be taken into 
consideration as well. One such limitation is the scope of the comorbid conditions that were 
examined. Several diagnoses, including ODD, CD, substance use disorders, and personality 
disorders were not evaluated categorically. Had these diagnostic categories been included, 
overall comorbidity rates may have been different. The absence of ODD, CD, and substance use 
disorders in particular may have had a meaningful impact, especially on observed gender 
differences. Such gender differences in turn may have been influenced by the relatively equal 
distribution of women and men within our sample. Although this distribution runs counter to the 
disproportionally higher rates of ADHD reported for men versus women in child populations 
(Nigg & Barkley, 2014), it may be the case that women enter college at disproportionally higher 
rates than men because women display higher rates of the inattentive ADHD presentation, which 
is less impairing. Another potential limitation is that our sample was drawn from college 
campuses in the United States, and therefore results cannot be generalized to college students 
with ADHD in other parts of the world. Similarly, our findings may not be applicable to 
emerging adults with ADHD who do not attend college, given that demands for self-regulation 
and access to treatment services may be very different for this population. The manner in which 
ethnic/racial diversity status was examined does not allow for a more refined analysis of how 
these demographic factors may impact comorbidity status. Yet another potential limitation is that 
our findings are based on self-report ratings, which may have been subject to feigning or other 
response biases. The current study also did not directly examine the impact of comorbidity on 
participants’ educational and social functioning, nor did it address the degree to which (a) 
identified comorbid conditions remain stable over time, and (b) new comorbid conditions 
develop during the college years. Comprehensive examination of these impairment and 
longitudinal issues is beyond the scope of the present article. These issues are, however, in the 
process of being examined as part of our ongoing TRAC study. 
Bearing such limitations in mind, the current findings have important implications for 
clinical practice. For example, to the extent that students with ADHD are entering college with 
preexisting comorbid problems, it is critically important for parents and high school educators to 
be keenly aware of these circumstances and to work together with students to ensure continuity 
of care during the transition to college. Likewise, in college and university settings, campus units 
that provide clinical and support services must be keenly aware of the strong possibility that 
students presenting with ADHD may have impairing comorbid conditions that should not be 
overlooked during evaluations and provision of treatment services (Shaw & Dukes, 2013). 
Knowledge of the possible influence of ADHD presentation and gender should also be taken into 
account when screening for comorbid conditions. 
In conclusion, the current findings address a gap in the literature and shed new light on 
the rates and patterns of comorbidity among emerging adults with ADHD in their 1st year of 
college. In so doing, this study provides a baseline for tracking the trajectories of ADHD and its 
comorbid features across this period of development. Tracking these trajectories, along with 
identification of associated risk and protective factors, ultimately can inform clinical assessment 
and treatment of this population. 
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